(R)-5-((4-(Methylamino)-5-(trifluoromethyl)pyrimidin-2-yl)-amino)-3-(pyrrolidin-3-ylamino)picolinonitrile

ID: ALA4862023

PubChem CID: 164622552

Max Phase: Preclinical

Molecular Formula: C16H17F3N8

Molecular Weight: 378.36

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CNc1nc(Nc2cnc(C#N)c(N[C@@H]3CCNC3)c2)ncc1C(F)(F)F

Standard InChI:  InChI=1S/C16H17F3N8/c1-21-14-11(16(17,18)19)8-24-15(27-14)26-10-4-12(13(5-20)23-7-10)25-9-2-3-22-6-9/h4,7-9,22,25H,2-3,6H2,1H3,(H2,21,24,26,27)/t9-/m1/s1

Standard InChI Key:  OPHFNMPIZSFHMD-SECBINFHSA-N

Molfile:  

 
     RDKit          2D

 27 29  0  0  0  0  0  0  0  0999 V2000
   21.0637  -23.7681    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   21.4805  -23.0556    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.6550  -23.0509    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   22.1957  -23.4680    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.1946  -24.2955    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.9094  -24.7083    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   23.6259  -24.2950    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.6231  -23.4644    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   22.9076  -23.0553    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.3410  -24.7064    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   25.0549  -24.2928    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.7667  -24.7046    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.4801  -24.2917    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   26.4793  -23.4657    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.7590  -23.0545    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.0487  -23.4697    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.4809  -22.2306    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   22.9051  -22.2302    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   23.6184  -21.8156    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.1895  -23.0533    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.9027  -22.6387    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   25.7549  -22.2294    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   26.4673  -21.8133    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.2211  -22.1399    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.7700  -21.5240    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.3537  -20.8115    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   26.5476  -20.9873    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  2  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9  4  1  0
  7 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 11  1  0
  4  2  1  0
  2 17  1  0
  9 18  1  0
 18 19  1  0
 20 21  3  0
 14 20  1  0
 15 22  1  0
 23 22  1  1
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 23  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4862023

    ---

Associated Targets(Human)

CHEK1 Tchem Serine/threonine-protein kinase Chk1 (6846 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MV4-11 (7307 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Z-138 (387 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KCNH2 Tclin HERG (29587 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 378.36Molecular Weight (Monoisotopic): 378.1528AlogP: 2.32#Rotatable Bonds: 5
Polar Surface Area: 110.58Molecular Species: BASEHBA: 8HBD: 4
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: 10.34CX Basic pKa: 10.11CX LogP: 0.58CX LogD: -1.58
Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.63Np Likeness Score: -1.42

References

1. Jin T, Xu L, Wang P, Hu X, Zhang R, Wu Z, Du W, Kan W, Li K, Wang C, Zhou Y, Li J, Liu T..  (2021)  Discovery and Development of a Potent, Selective, and Orally Bioavailable CHK1 Inhibitor Candidate: 5-((4-((3-Amino-3-methylbutyl)amino)-5-(trifluoromethyl)pyrimidin-2-yl)amino)picolinonitrile.,  64  (20.0): [PMID:34665631] [10.1021/acs.jmedchem.1c00994]

Source